Vistagen Therapeutics, Inc. (VTGN) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2011: $18.67M2012: $6.05M2013: $13.44M2014: $13.06M2015: $20.81M2016: $3.97M2017: $3.10M2018: $4.36M2019: $6.94M2020: $11.50M2021: $16.30M2022: $9.93M2023: $9.01M2024: $9.37M2025: $13.95M2026: $13.04M$13.04M
2011Total Liabilities (USD)2026
Fiscal YearTotal LiabilitiesChange YoY
2026$13.04M-6.5%
2025$13.95M+48.9%
2024$9.37M+4.0%
2023$9.01M-9.3%
2022$9.93M-39.1%
2021$16.30M+41.7%
2020$11.50M+65.8%
2019$6.94M+59.0%
2018$4.36M+40.9%
2017$3.10M-21.9%
2016$3.97M-80.9%
2015$20.81M+59.3%
2014$13.06M-2.8%
2013$13.44M+122.2%
2012$6.05M-67.6%
2011$18.67M